Drug Profile
Research programme: hepatitis C vVirus) vaccine - Sumagen
Latest Information Update: 21 Sep 2023
Price :
$50
*
At a glance
- Originator Sumagen
- Class Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Hepatitis C
Most Recent Events
- 21 Sep 2023 Hepatitis C virus vaccine research programme is still in preclinical phase for Hepatitis-C in South Korea (Parenteral, Injection) (Sumagen pipeline; September 2023)